Inside the research
Sabra Health Care REIT, Inc.
SBRA Research profile · latest available data
Price overview
$19.85
▲ +0.08 (+0.4%)
| 52w hi | $22.06 |
|---|---|
| 52w lo | $16.22 |
| Vol | 2.30M |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.04
| Short | +0.21 |
|---|---|
| Medium | -0.03 |
| Long | -0.15 |
computed 2026-09-27
Key fundamentals
Sabra Health Care REIT, Inc.
Real Estate · REIT - Healthcare Facilities
| Market cap | $5.07B |
|---|---|
| Enterprise value | $7.46B |
| Trailing P/E | 76.35x |
| Forward P/E | 24.51x |
| EV / EBITDA | 20.21x |
| P / S (ttm) | 5.87x |
| Profit margin | 7.6% |
| Return on equity | 2.4% |
| Revenue growth | +25.3% |
| Debt / equity | 95.67 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.19 | |
| Sector | -0.04 | |
| Technical | +0.09 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
Risk Metrics
| Beta vs SPX | 0.06 |
|---|---|
| Corr SPX | 0.04 |
| Annual vol | 23.8% |
| Annual ret | +6.0% |
| Sharpe | 0.25 |
| Max DD | -19.3% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-03 | Earnings Release, Reg FD Disclosure… | read |
| 2026-07-21 | Reg FD Disclosure, Exhibits | read |
| 2026-06-17 | Shareholder Vote | read |
| 2026-05-28 | Reg FD Disclosure, Exhibits | read |
| 2026-04-29 | Earnings Release, Reg FD Disclosure… | read |
| 2026-02-12 | Earnings Release, Reg FD Disclosure… | read |
| 2026-01-05 | Officer / Director Change, Reg FD Disclosure… | read |
| 2025-11-05 | Earnings Release, Reg FD Disclosure… | read |
| 2025-08-05 | Material Agreement, Termination of Agreement… | read |
| 2025-08-04 | Earnings Release, Reg FD Disclosure… | read |
| 2025-07-31 | Material Agreement, Material Obligation… | read |
| 2025-06-30 | Other Material Event | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Malehorn Jeffrey A. | Grant | 8.31K | — | |
| 2026-06-17 | Kono Ann | Grant | 8.31K | — | |
| 2026-06-17 | KATZMANN LYNNE S | Grant | 8.31K | — | |
| 2026-06-17 | FOSTER MICHAEL J | Grant | 8.31K | — | |
| 2026-06-17 | Cusack Catherine | Grant | 8.31K | — | |
| 2026-06-17 | Barbarosh Craig A. | Grant | 8.31K | — | |
| 2026-05-29 | Malehorn Jeffrey A. | Grant | 817 | — | |
| 2026-05-29 | Kono Ann | Grant | 817 | — | |
| 2026-05-29 | KATZMANN LYNNE S | Grant | 817 | — | |
| 2026-05-29 | FOSTER MICHAEL J | Grant | 817 | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 7 |
| Top-5 share | 96.9% |
| HHI | 4,481 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $240.08M | 12.31M |
| Fidelity / FMR LLC | $57.66M | 2.96M |
| AQR Capital Management | $39.00M | 2.00M |
| Millennium Management | $14.56M | 746.17K |
| Capital Research / Capital World | $11.93M | 611.43K |
| Citadel Advisors | $11.63M | 595.99K |
| T. Rowe Price Group | $6.30K | 323.00K |
As of 2026-06-30
Dividends
| Yield (TTM) | 3.02% |
|---|---|
| $ / share (TTM) | $0.60 |
| 5y CAGR | -2.3% |
Annual dividend per share
| 2021 | $1.20 |
|---|---|
| 2022 | $1.20 |
| 2023 | $1.20 |
| 2024 | $1.20 |
| 2025 | $1.20 |
| 2026 | $0.30 |
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $284.58M | +28.2% | |
| Net income | $155.61M | +148.4% | |
| Cash from ops | $300.57M | +31.4% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $19.75 | $19.89 | $19.59 | $19.85 | 2.30M |
| Sep 24 | $19.77 | $20.06 | $19.74 | $19.77 | 2.14M |
| Sep 23 | $19.78 | $19.91 | $19.66 | $19.69 | 3.03M |
| Sep 22 | $19.95 | $19.97 | $19.76 | $19.81 | 2.25M |
| Sep 21 | $19.78 | $20.09 | $19.71 | $19.87 | 2.01M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →